Jones Financial Companies’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,301
Closed -$438K 218
2018
Q3
$438K Buy
2,301
+57
+3% +$10.5K ﹤0.01% 176
2018
Q2
$374K Sell
2,244
-1,002
-31% -$161K ﹤0.01% 178
2018
Q1
$547K Sell
3,246
-2,057
-39% -$345K ﹤0.01% 163
2017
Q4
$867K Sell
5,303
-13,174
-71% -$2.36M ﹤0.01% 157
2017
Q3
$3.79M Buy
18,477
+5,380
+41% +$1.25M 0.01% 105
2017
Q2
$3.18M Buy
13,097
+4,219
+48% +$991K 0.01% 114
2017
Q1
$2.12M Buy
8,878
+2,676
+43% +$623K 0.01% 124
2016
Q4
$1.3M Buy
6,202
+3,322
+115% +$688K ﹤0.01% 136
2016
Q3
$663K Buy
2,880
+308
+12% +$75.3K ﹤0.01% 160
2016
Q2
$594K Buy
2,572
+1,708
+198% +$394K ﹤0.01% 165
2016
Q1
$231K Buy
864
+222
+35% +$63.5K ﹤0.01% 209
2015
Q4
$201K Buy
+642
New +$191K ﹤0.01% 227

Other funds holding AGN

Jones Financial Companies's AGN Position: Q4 2018 in Review

Jones Financial Companies sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 2,301 shares — an estimated $438K sold.

Jones Financial Companies first reported a position in AGN in Q4 2015 and held it in 12 quarters. The position peaked at $3.79M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Jones Financial Companies reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Jones Financial Companies sold 2,301 Allergan plc shares in Q4 2018, an estimated $438K.
  • Jones Financial Companies first reported a position in Allergan plc in Q4 2015 and held it in 12 quarters.
  • Jones Financial Companies's Allergan plc position peaked at $3.79M in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Jones Financial Companies's 13F filing for Q4 2018, filed 11 Feb 2019.